Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Psychiatry ; 68(12): 1939-45, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18162026

ABSTRACT

OBJECTIVE: On the basis of limited prior research on associations between symptoms and substance use in first-episode psychosis, a retrospective chart review was conducted to test 2 hypotheses: (1) the presence of positive symptoms is associated with alcohol use prior to admission and (2) the absence of prominent negative symptoms is associated with cannabis use prior to admission. METHOD: Eligible patients included those admitted for a first episode of psychosis in a public-sector, university-affiliated hospital that serves a predominantly African American, socially disadvantaged, urban population. The 72 patients included in the analysis were 18 to 40 years of age, and all were African American. Using a structured data collection instrument, discharge summaries of consecutively admitted patients from January 2002 to March 2005 were reviewed to extract data on basic demographic and clinical characteristics, the presence of 11 symptoms, and alcohol and cannabis use within 6 months prior to hospitalization. RESULTS: Alcohol use in the 6 months prior to hospitalization was associated with a higher frequency of positive psychotic symptoms among first-episode patients. Cannabis use was associated with a lower likelihood of having prominent negative symptoms. These associations remained even after controlling for relevant covariates in logistic regression models. CONCLUSION: Although the direction of causality cannot be established, the association between positive psychotic symptoms and alcohol use may represent a self-medication effect, whereas the association between lesser negative symptoms and cannabis use may result from the fact that interpersonal deficits and reduced hedonic capacity minimize drug-seeking activities.


Subject(s)
Alcohol Drinking , Marijuana Smoking , Schizophrenia/complications , Schizophrenia/ethnology , Adolescent , Adult , Female , Hospitals, University/statistics & numerical data , Humans , Male , Retrospective Studies , Schizophrenic Psychology , Severity of Illness Index , Southeastern United States , Urban Population
2.
Schizophr Res ; 69(2-3): 183-8, 2004 Aug 01.
Article in English | MEDLINE | ID: mdl-15469192

ABSTRACT

OBJECTIVE: The "estrogen hypothesis" posits that this hormone serves as a protective factor in the development of schizophrenia. If true, then it is expected that the earlier the age of menarche, the later the onset of schizophrenia (as has been reported by some investigators). This study attempts to replicate this relationship in a sample of women with schizophrenia and schizoaffective disorder. METHOD: Self-report menarche age, clinical status, and onset of disorder were collected in a sample of 68 women (55 diagnosed with schizophrenia and 13 with schizoaffective disorder). RESULTS: Menarche age and schizophrenia onset were not negatively correlated as would be predicted by the estrogen hypothesis. Two clinical measures, however, did correlate with age of menarche as predicted. Higher negative symptom scores (total SANS) and greater functional impairment (lower GAF) were reported in subjects who reported a later age at menarche. CONCLUSION: This study suggests that an earlier age at menarche might predict improved clinical outcome after schizophrenia onset (in support of the estrogen hypothesis). Our data, however, do not support Cohen et al.'s findings regarding the relationship between age at menarche, and the timing of the onset of the disorder. Further investigations regarding the relationship between estrogen and schizophrenia development in women are needed. It is suggested that other developmental factors, both biological and psychosocial, might play a crucial role in both the age at onset and the outcome of the disorder in women.


Subject(s)
Menarche/physiology , Schizophrenia/epidemiology , Schizophrenia/physiopathology , Adult , Age Factors , Age of Onset , Aged , Aged, 80 and over , Aging/physiology , Behavioral Symptoms , Female , Humans , Middle Aged
3.
Annu Rev Psychol ; 55: 401-30, 2004.
Article in English | MEDLINE | ID: mdl-14744221

ABSTRACT

Decades of research on schizophrenia have not produced major breakthroughs, but gradual progress has been made in identifying risk factors and clarifying the nature of the etiologic process. This article provides an overview of trends in research findings as well as current assumptions about the interplay between environmental and genetic factors in the etiology of schizophrenia. Based on the cumulative findings, it appears that both genetic and prenatal factors can give rise to constitutional vulnerability. Subsequent neuromaturational processes, especially those that occur during adolescence, and exposure to stressful events can trigger the behavioral expression of this vulnerability.


Subject(s)
Brain/abnormalities , Brain/physiopathology , Schizophrenia/etiology , Schizophrenia/physiopathology , Brain/metabolism , Cognition Disorders/etiology , Disease Progression , Dopamine/metabolism , Humans , Life Change Events , Schizophrenia/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...